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Abstract
Objective
Febrile seizure is the most common problem in pediatric neurology that occurs 
in 3– 4 % of children. The purpose of this study was to determine febrile seizure 
recurrence frequency and to evaluate its risk factors.
Materials & Methods
In a descriptive prospective study, 139 children (6 months to 6 years) with first 
febrile seizure were admitted to Yazd Shaheed Sadoughi Hospital between 
March 2004 and August 2005 and were followed up for at least 15 months for 
febrile seizure recurrence.
Results
Seventy six boys and 63 girls with a mean age of 2.03 ± 1.21 years were followed 
up for 25.1±5.5 months. 
About 30% of them had complex febrile seizures and 37.4% had febrile seizure 
recurrence with a mean recurrence time of 6.7 ± 5.9 months. About 65% of 
the children younger than one year and 30% of those older than one year had 
febrile seizure recurrence. (P value= 0.0001)
Recurrence of seizure was seen in 63% of those who had seizure within an 
hour from the onset of fever and in 33% of those who had seizure after one 
hour from the onset of fever. (P value = 0.005)
Seizures in children younger than one year old and seizures occurring in 
association with a fever lasting less than an hour were risk factors of febrile 
seizure recurrence. 
Conclusion
Febrile seizure is more disturbing in children younger than one year old. 
Antipyretic usage was not effective in preventing seizure recurrence but may 
reduce discomfort and is reassuring.
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Introduction
Febrile seizure (FS) is the most common type of childhood seizures(1). It is also a 
common cause of pediatric admission and parental concern. 
Based on population studies, FS cumulative incidence is 2–5% in Western Europe 
and the USA. The global incidence varies between 0.35% - 1.5% in China to 14% 
in Guam(2-4). Data from developing countries are limited, possibly because it 
may be very difficult to differentiate simple FS from acute symptomatic (infective) 
seizures, particularly if due to falciparum malaria infection(4).
International League Against Epilepsy defines FS as a seizure occurring in 
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association with a febrile illness in the absence of CNS 
infections or an acute electrolyte imbalance in children 
older than one month without prior afebrile seizures(4). 
This definition is similar to the one adapted earlier by 
the NIH Consensus Conference in 1980 while according 
to Berg, Febrile seizures occur between 6 months and 
6 years of age by definition(5). FS is rare before 9 
months and after 5 years of age (6) The child may be 
neurologically normal or abnormal.
Febrile seizures are further classified as simple and 
complex. A febrile seizure is complex if it is focal or 
focal findings are present during the postictal period, 
is prolonged more than 10 -15 minutes or is multiple 
(occurrence of more than one seizure during the febrile 
illness)(1).
Of all first FS, between 9% and 35% are complex 
(1,4). This wide variation may reflect the difficulties in 
differentiating simple from complex FS, and perhaps 
even differentiating FS from afebrile seizures(4).
One major concern in dealing with first FS is the risk 
of recurrence. It ranges from 21% to 43 % in different 
studies (7,8,9).
Risk factors for recurrence after first FS, based on 
different studies, are as follows:
1. Age under one year (1, 2,4 & 9 -20)
2. Family history of febrile seizures (1, 2, 4, 8 -15 & 
17- 23)
3. Seizure in temperatures below than 40º C (1, 2, 4, 
10-14, 17- 19 , 21)
4. FS within an hour of the recognized onset of fever (1, 
2, 12, 13)
5.Complex features (1, 2, 7, 9, 10, 12, 15, 16, 23): 
prolonged( 24), multiple (4,11), focal(17)
6. Family history of epilepsy (2, 13-17)
7. Male sex (7)
8. Parental consanguinity (16)
9. Attendance at day care centers (2,8)
10. Recurrent febrile seizure (25)
The most consistent risk factors are the first two. One 
of the most important risk factors is being younger than 
one year at first FS. Half of the children with onset in 
the first year and 28% with onset after first years of age 
experience recurrence. Recurrence decreases to 10% 
with onset after 3 years (10, 11, 26).
Neurodevelopmental abnormality is not associated with 
increased risk of recurrence(1).
Simple FS, especially in a child older than 12 months, 
is considered as a benign disease which requires 
neither specific tests [laboratory test, lumbar puncture, 
neuroimaging (CT or MRI), EEG], nor specific 
treatment(1), but complex FS is accompanied by further 
complications such as meningitis (1,27), recurrent FS 
(1, 2, 6, 7, 9, 10, 12, 15, 16, 23), subsequent epilepsy (1, 
2, 4, 9, 14, 25) and status epilepticus (1).
Preventing or aborting prolonged febrile seizures 
to prevent status epilepticus with its attendant 
complications, however, remains a rational goal. 25 
Diazepam given orally or rectally at the time of the onset 
of a febrile illness reduces the probability of a recurrent 
FS and is indicated particularly in children at risk of 
prolonged or multiple FS or in those who live far from 
medical care or to allay familial anxiety. 1Prophylatic 
daily anticonvulsant should be considered in infants with 
an abnormal neurological exam or developmental delay, 
complex febrile seizure with a positive family history of 
epilepsy and frequent and prolonged FS (26).
Multiple recurrences of FS predispose a child with FS 
to subsequent epilepsy(27-29).
The purpose of this study was to determine the recurrence 
rate of febrile seizures in children and to evaluate risk 
factors for recurrence in Yazd, a central city in Iran.
Materials and Methods 
In a descriptive prospective study, 139 children (6months 
to 6years) with first febrile seizure were admitted to Yazd 
Shaheed  Sadoughi Hospital between March 2004 and 
August 2005 and were followed up for 15- 36 months for 
seizure recurrence. We made use of Berg definition for 
the age range of 6 months - 6 years in FC. Children with 
a history of afebrile seizure, evidence of central nervous 
infection, shigellosis encephalopathy and electrolyte 
abnormalities were excluded. Maximum temperature was 
defined as the highest rectal temperature recorded during 
the period of admission. The patient’s characteristics, 
i.e., sex and age at the time of febrile seizure, type and 
duration of the seizure, the first presentation as being 
a simple or a complex febrile seizure, positive family 
history of febrile/afebrile seizures in the first and second 
degree relatives, duration of fever, developmental 
status, and maximum temperature were reviewed. The 
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developmental status of the patient was assessed by a 
pediatrician and a pediatric neurologist based on Denver 
Developmental screening test. Data was analyzed 
using SPSS.15 statistical software. Unpaired t test and 
chi-square test were used to compare continuous and 
categorical variables, respectively, between groups with 
and without the recurrence of febrile seizure. Risk factors 
were initially examined by univariate analysis. Rate 
ratios were calculated for individual risk factors with a 
95% confidence interval. Multivariate Cox regression 
analysis was used to examine the risk of recurrence after 
adjustment for individual risk factors. The Kaplan-Meier 
method was used to calculate probability of recurrence 
during the follow-up period. Statistical significance was 
taken as P < 0.05. 
This study was approved by the ethic committee of 
Shaheed Sadoughi University of Medical Sciences, 
Yazd, Iran.
Results
Seventy six boys and 63 girls with a mean age of 2.03 
± 1.21 years were followed up for 25.1±5.5 months. 
The male/female ratio was 1.2/1. Sixty-seven percent 
(n = 93) of them presented with simple febrile seizure 
whereas 33% (n = 46) presented with complex features. 
Among those with complex febrile seizures, 23 had 
multiple convulsions within 24 hours whereas 9 had 
focal features and 14 had prolonged convulsion. Number 
of first febrile seizure per age was as follows: < 1year 
(29), 1-2 years (63), 2-4 years (39) and > 4 years (8).
Of all seizures, 66 % were in children younger than two 
and 6 % occurred in children older than four years.
 Mean seizure duration was 8±5.6 minutes in children 
younger than one year and 6.7±5.3 minutes in those 
older than one year. Seizure was more prolonged in 
those <1 year (P value= 0. 04).
Fifty two patients had recurrent febrile seizures with a 
mean recurrence time of 6.7 ± 5.9 months. The overall 
recurrence rate was 37.4% by the Kaplan-Meier method. 
Cumulative recurrence was 11.5% by one month, 67.3% 
by six months, 88% by one year and 94% by 18 months. 
Recurrence rate displayed no further increasing trend 
by 2 years after the first episode, indicating that febrile 
seizure is unlikely to recur if a child does not experience 
any recurrence in 2 years after the first febrile seizure. 
Of the 52 who experienced recurrence, 67% (35/52) had 
one, 23% (12/52) had two, and 10% (5/52) had more 
than two episodes of recurrence.
Sixty five percent (19/29) of the children younger than 
one year and 30% (33/110) of those more than one year 
had febrile seizure recurrence (P value= 0.0001).
In those <1 year, 48% (14/29) had one, 14% (4/29) 
had two, and 3.4 % (1/29) had more than two episodes 
of recurrence. In 1 – 2 year old children, 22% (14/63) 
had one, 9.5% (6/63) had two, and 4.8% (3/63) had 
more than two episodes of recurrence. In 2 - 4 year old 
children, 18 % (7/39) had one, 5% (2/39) had two, and 
2.6 % (1/39) had more than two episodes of recurrence. 
In other  words,  In >1year old children, 19 % (21/110) 
had one, 7.2 % (8/110) had two, and 3.6 % (4/110) had 
more than two episodes of recurrence and therefore the 
number of  the episodes of recurrence was more in those 
<1 year (p = 0.04).
Recurrence of seizure was seen in 63% of those who 
had seizure within an hour from the onset of fever and 
in 33% of those who had seizure after one hour from the 
onset of fever (P value = 0.005).
Thirty two cases of simple FS (34%) and 20 cases of 
complex FS (43%) had recurrent FS (P value=0.298).
Forty percent (34/86) of the children who used 
antipyretic in other febrile episodes and 34% (18/53) 
of those without antipyretic use had febrile seizure 
recurrence. Statistical analysis showed that antipyretic 
usage was not effective in preventing febrile seizure 
recurrence (P value = 0.5).
Mean recurrence time in different age groups is shown 
in Table 1. It can be seen that in children older than 4 
years, FS recurs later (P value = 0.014).
Six children had neurodevelopmental delay (NDD) 
among whom occurrence of the first FS in the first year 
of life was seen in two while four others experienced FS 
between 1 and 2 years of age. These four patients had 
recurrence of FS. Two of them (33% of NDD) had one 
episode of recurrence and 33% (2/6) or the other two 
had two episodes. Twenty five percent (33/133) of the 
children with a normal developmental status showed 
one, 7.5% (10/133) showed two, and 3.7 % (5/133) 
showed more than two episodes of recurrence. The two 
groups were not significantly different in this regard (P 
value = 0.224).
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Developmental status of the children did not change in 
the end of the follow up period. 
Subsequent epilepsy occurred in 50% (3/6) of the 
children with NDD and 4.5% (6/133) of the children 
without NDD and the frequency of subsequent epilepsy 
in NDD patients was higher (P value = 0.0001).
Table 2 demonstrates some data regarding the use of 
prophylactic drugs (daily phenobarbital or diazepam in 
the fever episode) in our patients. However, analysis of 
such data does not seem to be logical because methods 
of selecting patients are not universal and antiepileptic 
treatment is prescribed in complicated FS. Therefore, 
randomized clinical trials should be done in these 
situations. 
Subsequent epilepsy was seen in 9 children. About 
13.5% (7/52) of the children with recurrent FS and 
2.3% (2/87) of those without recurrent FS suffered from 
subsequent epilepsy. Frequency of epilepsy was higher 
in children with recurrent FS (P value = 0.01). 
Univariate analysis of other factors is showed in 
Table 3. Sex, seizure type, FS type, fever height, 
neurodevelopmental status, positive family history of 
febrile seizure or epilepsy, seizure duration and EEG 
result were not related to febrile seizure recurrence.
Multivariate analysis disclosed that two factors were 
statistically significant: seizure in children younger 
than one year old and seizures occurring in association 
with a fever lasting less than an hour and they remained 
significant in Cox regression analysis. The rate ratio 
(RR) was 1.6 (95% confidence interval [CI] = 1.2 -
2.23 and P value = 0.0001) for early age of onset and 
1.7 (95% CI= 1.45 – 2. 23, P value = 0.02) for fever 
duration of less than one hour.
Table 1. Comparison of mean recurrence time in different age groups
Age group Total number Number of recurrent FS mean recurrence time (mo) ± SD
< 1 years 29 19 5.57±  4.7
1 – 2 years 63 23 6.09±  5.4
2 – 4 years 39 10 10.7±8.3
> 4 years 8 0 0
Table 2. Frequency of febrile seizure recurrence (in numbers) based on prophylactic drugs
Drug  use
Febrile seizure recurrence  
No drugs Diazepam during  fever Continuous  phenobarbital Total
Without 62 15 10 87
With 42 1 9 52
Total 104 16 19 139
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Table 3. Risk factors for recurrence of febrile seizure using univariate analysis 
Factor Recurrence No Recurrence P Value
Age at first seizure
< 1year 19 10
0.0001
> 1year 33 77
Fever  duration 
<  1 hour 12 7
0.01
>  1 hour 40 80
Sex 
Male 24 52
0.119
Female 28 35
Seizure in T <40°c 
Yes 51 84
0.6
no 1 3
Positive  family history of FS 
in 1st-2nd  degree relatives 
Yes 13 15
0.27
No 39 72
Positive  family history of 
epilepsy  in 1st-2nd  degree 
relatives
Yes 10 11
0.294
No 42 76
developmental delay
Yes 4 2
0.13
no 48 85
Seizure duration>10min
Yes 8 6
0.269
No 44 81
Seizure type 
Generalized 50 80
0.45Focal 2 4
Secondary generalized 0 3
EEG results 
Normal 18 13
0.46Nonspecific abnormal 22 11
Epileptic abnormality 3 4
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Discussion 
The purpose of this study was to determine febrile 
seizure recurrence frequency and to evaluate its risk 
factors. In this study, Boys were affected slightly more 
than girls which supports other studies (1, 2, 4, 22 & 
30-34).
One third of our patients had complex febrile seizures 
but in other studies, this rate varies between 6.7% and 
35% (1, 4, 23, 24, 30 & 34 -36). Possible explanations 
for this variety are ethnical and geographic differences, 
better diagnosis of partial seizures, methods of selecting 
patients, etc.
 In the present study, seizures were more prolonged in 
infants (<1 year) that is similar to the results of a study 
by Farwell(35).
In this study, 13.7% of the children experienced their 
seizure either before or within 1 hour of the onset of 
fever which is lower than that of the Berg’s study (21%) 
(18). On the other hand , FS occurred in spite of full dose 
use of antipyretic in 62% of the patients and therefore 
administration of antipyretic had no effects on febrile 
seizure recurrence which is in agreement with other 
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studies indicating that prophylactic antipyretic is not 
recommended to reduce FS recurrence rate(3, 37-40). 
The recurrence  rate  of  febrile seizure in the present 
study was 37% that is similar to some other studies (1, 2, 
4, 11, 12, 15, 25, 41); however, this rate varies between 
15% and 48% (7, 8, 9, 12, 21) Possible explanations for 
this difference are the follow-up duration, ethnical and 
geographical differences,  methods of selecting patients 
and the sample size.
Onset of febrile seizure at a young age is reported to 
be the most consistent risk factor for febrile seizure 
recurrence in some studies (1, 2, 4, 6, 9 -20). In this study, 
65% of the children younger than one year experienced 
febrile seizure recurrence. This figure is more than 50% 
in other studies (1, 10, 30). In one study, this rate was 
73% (14). More prolonged seizures in infants may be a 
possible explanation for the results of our study.
In the present study, EEG results had no value in 
predicting the recurrence of febrile seizure as in other 
studies (2, 11, 42, 43) and it is recommended that EEG 
should be done in children with complex febrile seizures 
who have a recurrence without fever or in children with 
recurrent febrile seizures who exhibit developmental 
delays or neurologic deficits(1,44). In this study, seizure 
within an hour of the recognized onset of fever was 
one of the risk factors for FS recurrence, which is in 
agreement with other studies (1,10.30.40). In our study, 
complex FS was not associated with increased risk 
of FS recurrence which is in compliance with other 
studies (1,17,18,20,21,28) but does not agree with 
some other studies(1, 2,6,7, 9,10,12,15,16,23). Possible 
explanations for this discrepancy are the number of the 
patients, methods of selecting patients, better diagnosis 
of partial seizures, etc. 
Seizure in temperatures lower than 40 °c was not a risk 
factor of FS  recurrence in the present study which does 
not agree with other studies (1, 2 ,4, 10 -14, 17- 19, 
21).
Gender was not associated with increased risk of 
FS recurrence in this study which supports pediatric 
textbooks(1).
In this study , NDD was not a risk factor of FS recurrence 
which is in compliance with other studies (1,17,18, 20, 
24). In the present study, recurrence rate (37%) was 
higher than that of Kashan-Iran study (24% ) which 
was a  one year follow-up of 50 children with FS and 
Fisher’s exact test was used for statistical analysis of 
the data. In that study, a positive family history of FS, 
occurrence of seizure within an hour from the onset of 
fever and in children younger than one year were risk 
factors of febrile seizure recurrence(45). 
In conclusion, In this study, seizure in children younger 
than one year old was one of risk factors of febrile 
seizure recurrence and they had more prolonged 
seizure. Therefore, febrile seizure must be considered 
more serious in this age group and recurrent FS must be 
followed more exactly. 
Antipyretic administration was not effective in 
preventing seizure recurrence but active measures to 
control fever, including the use of antipyretics, may 
reduce discomfort and are reassuring.
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